The two organizations will launch clinical trials using AI to explore how the technology can be used for cardiovascular disease research, as well as how it can prevent bias, according to an Oct. 5 news release from Mount Sinai.
Chiba researchers, who are located in Japan, will fly to Mount Sinai to learn more about cardiovascular care used by the health system, and Mount Sinai researchers will visit Japan to explore the technological advancements of Chiba.
The aim of the collaboration is to identify new treatments for patients with cardiovascular disease, as well as gain greater knowledge on how to better prevent the disease.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.